(Q43409467)

23 November 2017

A novel murine model of severe pulmonary arterial hypertension (English)

1 reference

23 November 2017

1 reference

1

Loredana Ciuclan

1 reference

23 November 2017

10

Gabor Jarai

1 reference

23 November 2017

4

Nicholas Duggan

1 reference

23 November 2017

Olivier Bonneau

2

1 reference

23 November 2017

Martin Hussey

3

1 reference

23 November 2017

Alan M Holmes

5

1 reference

23 November 2017

Robert Good

6

1 reference

23 November 2017

Rowan Stringer

7

1 reference

23 November 2017

Peter Jones

8

1 reference

23 November 2017

Nicholas W Morrell

9

1 reference

23 November 2017

Christoph Walker

11

1 reference

23 November 2017

John Westwick

12

1 reference

23 November 2017

Matthew Thomas

13

1 reference

23 November 2017

language of work or name

English

0 references

publication date

25 August 2011

1 reference

American Journal of Respiratory and Critical Care Medicine

23 November 2017

1 reference

23 November 2017

184

1 reference

23 November 2017

10

1 reference

23 November 2017

1171-1182

1 reference

Cellular and molecular pathobiology of pulmonary arterial hypertension

23 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Cellular and molecular basis of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Pathogenic mechanisms of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

[Treatment of pulmonary arterial hypertension in 2011: what's new since the 2009 ERS/ESC guidelines?].

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Biomarkers in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Hypoxia and chronic lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by mo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

TGF-beta enhances alcohol dependent hepatocyte damage via down-regulation of alcohol dehydrogenase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Optimizing dosage of ketamine and xylazine in murine echocardiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

How valid are animal models to evaluate treatments for pulmonary hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Echocardiography in translational research: of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Endothelial cell apoptosis in chronically obstructed and reperfused pulmonary artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Reversal of experimental pulmonary hypertension by PDGF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Physiopathology of pulmonary arterial hypertension. Cellular and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Current insights on the pathogenesis of pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Rodent models of PAH: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0412OC

10.1164/RCCM.201103-0412OC

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference